Waldencast plc [WALD] vs Colgate-Palmolive [CL] Detailed Stock Comparison
Waldencast plc
NASDAQ
Loading...
Colgate-Palmolive
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Waldencast plc wins in 6 metrics, Colgate-Palmolive wins in 10 metrics, with 0 ties. Colgate-Palmolive appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Waldencast plc | Colgate-Palmolive | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 23.62 | N/A |
| Price-to-Book Ratio | 0.26 | 96.74 | Waldencast plc |
| Debt-to-Equity Ratio | 24.95 | 832.51 | Waldencast plc |
| PEG Ratio | -15.60 | 21.78 | Waldencast plc |
| EV/EBITDA | 676.12 | 15.68 | Colgate-Palmolive |
| Profit Margin (TTM) | -15.50% | 14.54% | Colgate-Palmolive |
| Operating Margin (TTM) | -18.31% | 20.86% | Colgate-Palmolive |
| EBITDA Margin (TTM) | N/A | 20.86% | N/A |
| Return on Equity | -6.49% | 398.04% | Colgate-Palmolive |
| Return on Assets (TTM) | -3.32% | 15.56% | Colgate-Palmolive |
| Free Cash Flow (TTM) | $-11.83M | $3.55B | Colgate-Palmolive |
| Dividend Yield | N/A | 2.29% | N/A |
| 1-Year Return | -57.67% | -22.30% | Colgate-Palmolive |
| Price-to-Sales Ratio (TTM) | 0.70 | 3.40 | Waldencast plc |
| Enterprise Value | $409.73M | $75.64B | Colgate-Palmolive |
| EV/Revenue Ratio | 1.50 | 3.78 | Waldencast plc |
| Gross Profit Margin (TTM) | N/A | 60.06% | N/A |
| Revenue per Share (TTM) | $2 | $25 | Colgate-Palmolive |
| Earnings per Share (Diluted) | $-0.39 | $3.56 | Colgate-Palmolive |
| Beta (Stock Volatility) | -0.53 | 0.35 | Waldencast plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Waldencast plc vs Colgate-Palmolive Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Waldencast plc | 6.71% | -8.02% | -18.13% | -37.92% | -53.00% | -60.16% |
| Colgate-Palmolive | -0.19% | -0.76% | 0.54% | -7.51% | -9.70% | -7.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Waldencast plc | -57.67% | -82.87% | -84.87% | -84.87% | -84.87% | -84.87% |
| Colgate-Palmolive | -22.30% | 7.41% | 9.20% | 35.35% | 122.96% | 214.25% |
Performance & Financial Health Analysis: Waldencast plc vs Colgate-Palmolive
| Metric | WALD | CL |
|---|---|---|
| Market Information | ||
| Market Cap | $32.08M | $75.32B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 870,850 | 4,750,930 |
| 90 Day Avg. Volume | 385,483 | 4,797,183 |
| Last Close | $1.59 | $83.65 |
| 52 Week Range | $1.48 - $4.39 | $82.40 - $109.30 |
| % from 52W High | -63.82% | -23.47% |
| All-Time High | $12.10 (Oct 03, 2022) | $109.30 (Sep 02, 2024) |
| % from All-Time High | -86.86% | -23.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.01% |
| Quarterly Earnings Growth | N/A | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | -0.16% | 0.15% |
| Operating Margin (TTM) | -0.18% | 0.21% |
| Return on Equity (TTM) | -0.06% | 3.98% |
| Debt to Equity (MRQ) | 24.95 | 832.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.91 | $0.87 |
| Cash per Share (MRQ) | $0.13 | $1.75 |
| Operating Cash Flow (TTM) | $-8,820,000 | $3.92B |
| Levered Free Cash Flow (TTM) | $8.34M | $2.73B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.29% |
| Last 12-Month Dividend | N/A | $2.02 |
Valuation & Enterprise Metrics Analysis: Waldencast plc vs Colgate-Palmolive
| Metric | WALD | CL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 23.62 |
| Forward P/E | -15.60 | 21.78 |
| PEG Ratio | -15.60 | 21.78 |
| Price to Sales (TTM) | 0.70 | 3.40 |
| Price to Book (MRQ) | 0.26 | 96.74 |
| Market Capitalization | ||
| Market Capitalization | $32.08M | $75.32B |
| Enterprise Value | $409.73M | $75.64B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.50 | 3.78 |
| Enterprise to EBITDA | 676.12 | 15.68 |
| Risk & Other Metrics | ||
| Beta | -0.53 | 0.35 |
| Book Value per Share (MRQ) | $5.91 | $0.87 |
Financial Statements Comparison: Waldencast plc vs Colgate-Palmolive
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WALD | CL |
|---|---|---|
| Revenue/Sales | $0 | $4.91B |
| Cost of Goods Sold | N/A | $1.92B |
| Gross Profit | N/A | $2.99B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-4.40M | $1.08B |
| EBITDA | $-11.30M | $1.17B |
| Pre-Tax Income | $2.77M | $953.00M |
| Income Tax | N/A | $227.00M |
| Net Income (Profit) | $2.77M | $726.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WALD | CL |
|---|---|---|
| Cash & Equivalents | $14.80M | $1.11B |
| Total Current Assets | $103.62M | $5.81B |
| Total Current Liabilities | $76.89M | $6.86B |
| Long-Term Debt | $149.86M | $6.57B |
| Total Shareholders Equity | $729.94M | $733.00M |
| Retained Earnings | $-289.20M | $26.41B |
| Property, Plant & Equipment | $0 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WALD | CL |
|---|---|---|
| Operating Cash Flow | $5.41M | $657.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-1.59M | $476.00M |
| Debt Repayment | N/A | $-4.00M |
| Common Stock Repurchase | N/A | $-284.00M |
Short Interest & Institutional Ownership Analysis
| Metric | WALD | CL |
|---|---|---|
| Shares Short | 585,305 | 12.03M |
| Short Ratio | 4.43 | 2.55 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 870,850 | 4,750,930 |
| Average Daily Volume (90 Day) | 385,483 | 4,797,183 |
| Shares Outstanding | 122.50M | 812.57M |
| Float Shares | 32.85M | 757.87M |
| % Held by Insiders | 0.57% | 0.00% |
| % Held by Institutions | 0.30% | 0.86% |
Dividend Analysis & Yield Comparison: Waldencast plc vs Colgate-Palmolive
| Metric | WALD | CL |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.02 |
| Last 12-Month Dividend Yield | N/A | 2.29% |
| 3-Year Avg Annual Dividend | N/A | $1.95 |
| 3-Year Avg Dividend Yield | N/A | 0.59% |
| 3-Year Total Dividends | N/A | $5.85 |
| Ex-Dividend Date | N/A | Apr 17, 2025 |